反相高效液相色谱法测定α-(2-氨基噻唑-4-基)-α-[(叔-丁氧基羰基)异丙氧亚胺基]-乙酸

提出了制备头孢类抗生素的中间体α-(2-氨基噻唑-4-基)-α[(叔-丁氧基羰基)异丙氧亚胺基]-乙酸(ATIA)的反相高效液相色谱测定方法,采用SpherigelTM C18色谱柱(250 mm×4.6 mm,5μm),以0.05 g·L-1四丁基溴化铵的甲醇-水(6+4)溶液为流动相,流速为1 mL·min-1,柱温30℃,检测波长260 nm,以外标法定量.在0.001～1.0 mg范围内,ATIA的质量与峰面积呈线性关系,回归方程为A=31 475.6m+1 786.7,相关系数为0.999 7,以质量为0.06 mgATIA按方法测定6次,算得其相对标准偏差为3.7%,检出限(3S)为0.6μg,回收率的试验结果在98.8%～104.0%之间.     

液相色谱-四级杆飞行时间质谱法检验血液中的3-氯甲卡西酮

本研究建立了液相色谱-四级杆飞行时间质谱(LC-QTOF-MS)检验血样中3-氯甲卡西酮(3-CMC)的方法。血液经1:2体积的乙腈沉淀蛋白后,采用Agilent?ZORBAX Eclipse Plus C18色谱柱(3.0 mm×150 mm,1.8μm)分离,0.1%(v/v)甲酸-水(5mol·L~(-1)乙酸铵)和乙腈作为流动相梯度洗脱,电喷雾双喷离子源电离正离子模式(Dual AJS ESI+)扫描。3-氯甲卡西酮在5～500ng·mL~(-1)范围内线性关系良好,检出限和定量限分别为2ng·mL~(-1)和5ng·mL~(-1),回收率在103.6%～113.7%之间,日内精密度小于8.1%,日间精密度小于11.8%。本方法可以对血液中的3-氯甲卡西酮进行定性定量检测,能够满足实际检案的要求。     

新型3-氧-3-芳基-2-芳基腙-丙腈衍生物的合成及其抗癌活性

以取代苯甲酸、乙腈和取代苯胺为原料,经4步反应合成了31个3-氧-3-芳基-2-芳基腙-丙腈衍生物(5a~5z和5Ⅰ~5Ⅴ),其中5a~5z为新化合物,其结构经1H NMR,13C NMR和MS表征。以STAT3抑制剂姜黄素和Stattic为对照,测试了5对人肝癌细胞、人前列腺癌细胞、人乳腺癌细胞(三株STAT3相关细胞)及小鼠胚胎细胞(STAT3低表达细胞)的抑制活性。结果表明:3-氧-3-(4'-氯苯基)-2-(4″-乙酰苯腙)-丙腈(5e)对受试细胞均有较好的抑制活性,IC50分别为6.01μmol·L-1,7.10μmol·L-1,9.00μmol·L-1和9.89μmol·L-1。     

1-(4-硝基苯基)-3-(2-吡嗪)-三氮烯的合成及与镉(Ⅱ)的显色反应

报道了显色剂1-(4-硝基苯基)-3-(2-吡嗪)-三氮烯化合物的合成及其与镉(Ⅱ)的显色反应。在非离子表面活性剂Triton X-100存在下,pH 10.5的Na2B4O7-NaOH的缓冲介质中,该试剂能与镉(Ⅱ)与发生显色反应,形成摩尔比为4∶1的黄棕色配合物,配合物在波长453 nm处有最大吸收峰,表观摩尔吸光系数ε为6.90×104L.mol-1.cm-1,镉(Ⅱ)质量浓度在0~0.56μg/mL范围内遵守比尔定律。用拟定方法测不同废水中的镉(Ⅱ)。     

吹扫捕集-气相色谱-质谱法同时测定水中11种醚类化合物

采用已加入4g质量比为3∶1的碳酸钠和氯化钠的混合物(盐析剂)的40mL棕色硼硅玻璃瓶采集水样,使水样充满样品瓶。采用吹扫捕集-气相色谱-质谱法同时测定水样中11种醚类化合物的含量。在气相色谱分离中采用HP-VOC色谱柱(90m×0.32mm,1.8μm),在质谱分析中采用选择离子监测模式。以氟苯为内标,环氧乙烷、环氧丙烷、四氢呋喃的线性范围均为5.0～100μg·L~(-1),其他8种醚类化合物的线性范围均为0.50～50μg·L~(-1),检出限为0.113～2.62μg·L~(-1)。以空白管网末梢水样品为基体进行加标回收试验,所得回收率为85.3%～115%,测定值的相对标准偏差(n=6)为3.0%～9.4%。     

瓶装饮用水中高氯酸盐含量的离子色谱-电导检测法和离子色谱-串联质谱法测定研究

建立了离子色谱-电导检测法(IC-CD)和离子色谱-串联质谱法(IC-MS/MS)测定瓶装饮用水中高氯酸盐浓度的方法,并对两种方法进行F检验(精密度)和t检验(系统误差)。结果表明,IC-CD的检出限为0.35μg·L~(-1),定量限为1.17μg·L~(-1),在0.5～8.0μg·L~(-1)范围内呈线性关系(R~(2 )=0.9993),相对标准偏差(RSD)为4.55%(n=7),加标回收率为99.50%～104.81%。IC-MS/MS的检出限为0.01μg·L~(-1),定量限为0.04μg·L~(-1),在0.05～20.00μg·L~(-1)范围内呈线性关系(R~2=0.9998),其RSD为1.21%(n=7),加标回收率为96.40%～102.52%。F检验和t检验表明两种方法在各自的线性范围内,检测方法准确可靠。根据建立的方法对瓶装饮用水中高氯酸盐含量进行测定,结果发现瓶装饮用水中高氯酸盐的浓度均低于美国环境保护署所提出的暂定安全浓度限量值(15.0μg·L~(-1))。     

高效液相色谱-串联质谱法测定水果中多果定残留量

提出了水果中多果定残留量的高效液相色谱串联质谱分析方法。样品经甲醇振荡提取3～5 min,离心分离取上清液蒸发至干。用流动相溶解残渣,经BEH C_(18)色谱柱(2.1mm×100)mm,1.7μm)分离,用乙腈与5mmol·L~(-1)乙酸铵溶液按体积比80比20混合作为流动相进行淋洗,采用正离子模式多反应监测。定性离子对为m/z 185.9,56.7,定量离子为m/z 56.7。多果定的质量浓度与其峰面积在5.0～500.0μg·L~(-1)范围内呈线性关系,测定下限(10S/N)为0.04mg·kg~(-1)。以水果样品为基体,加入3种不同浓度的多果安标准溶液做回收试验,测得回收率在80.0%～104.6%之间,相对标准偏差在4.3%～14%之间。     

超高效液相色谱-四极杆-飞行时间质谱法定性筛查和定量分析血液中110种农药

建立了超高效液相色谱-四极杆-飞行时间质谱法(UPLC-Q-TOF/MS)同时分析血液中110种农药的方法。在2mL离心管中,加入200μL血液样品和1 000μL甲醇,混合均匀,涡旋振荡2min,离心10min,取上清液在优化的仪器工作条件下进行测定。采用Kinetex Biphenyl色谱柱为固定相,以5mmol·L~(-1)甲酸铵溶液(A)和含5mmol·L~(-1)甲酸铵的甲醇溶液(B)的混合溶液为流动相进行梯度洗脱。在电喷雾离子源正离子(ESI+)模式和信息依赖采集(IDA)模式下,依次采集一级和二级质谱信息。采用Master View软件通过质量误差、保留时间误差、差异同位素比、谱库相似程度等4个因子获得的综合得分来进行定性筛查;采用Multi Quant软件通过提取离子流(XIC)色谱图中的前体离子的峰面积进行定量分析。结果表明:110种目标农药化合物的综合得分为81.8～97.0分,所得结果均大于定性筛查的最低限(80分)。110种目标农药化合物的质量浓度在5～200μg·L~(-1)内与其对应的色谱峰面积呈线性关系,相关系数在0.99以上,检出限(3S/N)为2μg·L~(-1)。以空白血为基质进行3个浓度水平的加标回收试验,目标农药的回收率为80.3%～120%,测定值的相对标准偏差(n=6)为1.9%～20%。以混合标准溶液和用空白基质配制的同浓度的混合标准溶液中各农药的峰面积的比值评估基质效应,110种农药的基质效应为80.65%～119.86%。采用此方法分析了2起农药中毒案件中的血液样品,分别检出了敌敌畏、毒死蜱、氯氰菊酯(案件1)和阿特拉津、氯氟氰菊酯、克百威(案件2),其定性筛查中4个因子的综合得分均大于80分,质量浓度分别为183.98,156.79,104.67μg·L~(-1)和144.57,165.32,138.91μg·L~(-1)。     

Myceliothermophin E片断(Z)-5-(2-甲基亚丙基)-3-吡咯啉-2-酮的合成及其 Baylis-Hillman 模型反应

采用两种方法合成了天然产物Myceliothermophin E片断(Z)-5-(2-甲基亚丙基)-3-吡咯啉-2-酮(1).方法一是以链状化合物为原料通过改良的HWE反应制备顺式α,β-不饱和酯；再经分子内亲核取代反应进行环合、消除反应制得1；方法二则以吡咯为原料,经Mukaiyama Aldol反应引入C5-位取代基,再经过消除反应制得1.(E)-11(合成1的中间体)与无水乙醛进行Baylis-HiUman反应,为Myceliothermophin E的全合成提供了一个可能的模型反应.     

高效液相色谱法测定制药中间体7-甲氧基-1-萘基乙腈

提出了用高效液相色谱法测定制备抗抑药物中间体7-甲氧基-1-萘基乙腈含量的方法.采用Diamonsil-C18色谱柱(250 mm×4.6 mm,5μm)进行分离,柱温为20℃,用甲醇-水(80+20)的混合液为流动相,流量为0.8 mL·min-1,检测波长为231 nm,进样量为20μL.结果表明:在此色谱条件下,7-甲氧基-1-萘基乙腈与相关杂质得到了分离.7-甲氧-基-1-萘基乙腈的质量浓度在2～48 mg·L-1范围内呈线性关系,方法的检出限(3S/N)为105μg·L-1.在40 mg·L-1浓度水平上平行测定6次,对方法的精密度和回收率做试验,测得其相对标准偏差为0.034%,平均回收率为99.7%.     

(S)-(-)-5-对苄氧基苄基-2,4-噁唑烷二酮的合成

L-酪氨酸经O-苄基化和重氮化反应得到关键中间体--手性3-(对苄氧基苯基)-α-羟基丙酸(4); 4经酯化、氨化和环化反应合成了(S)-(-)-5-对苄氧基苄基-2,4-噁唑烷二酮,总收率10%, 95.4%e.e.,其结构经1H NMR和HR-MS表征.     

(S)-(-)-norlaudanosine和(S)-(-)-O,O-dimethylcoclaurine的合成

以高藜芦胺为起始原料,经N-磺酰化反应制得高藜芦磺酰胺(2);2分别与芳乙烯甲醚经对甲苯磺酸催化的Pictet-Spengler反应后用金属钠脱除Ts基团合成了(±)-norlaudanosine(5a)和(±)-O,O-dimethylcoclaurine(5b);使用半量拆分法,以N-乙酰-L-苯丙氨酸为拆分剂,制得(S)-(-)-5a和(S)-(-)-5b,其结构经1H NMR,13C NMR,IR,MS和HR-ESI-MS确证。     

Preparation,molecular structures,and characteristic properties of (E)-1-(2-furyl)- and (E)-1-(2-thienyl)-2-(3-guaiazulenyl)ethylenes and (E)-1-(3-furyl)- and (E)-1-(3-thienyl)-2-(3-guaiazulenyl)ethylenes

Wittig reactions of 2-furaldehyde (20) [and thiophene-2-carbaldehyde (21)] with (3-guaiazulenylmethyl)triphenylphosphonium bromide (19) in ethanol containing NaOEt at 25 °C for 24 h under argon give (E)-1-(2-furyl)-2-(3-guaiazulenyl)ethylene (22E) and (E)-1-(2-thienyl)-2-(3-guaiazulenyl)ethylene (23E) in 53 and 36% yields. Similarly, Wittig reactions of 3-furaldehyde (29) [and thiophene-3-carbaldehyde (30)] with 19 under the same reaction conditions as for 20 and 21 afford (E)-1-(3-furyl)-2-(3-guaiazulenyl)ethylene (31E) and (E)-1-(3-thienyl)-2-(3-guaiazulenyl)ethylene (32E) in 32 and 46% yields. Molecular structures and characteristic properties as well as preparation of the title E (i.e., one of the geometrical isomers) forms, with a view to comparative study, are reported. Moreover, reactions of those conjugated π-electron systems with TCNE (=tetracyanoethylene) in benzene [and in DMF (=N,N-dimethylformamide)] at 25 °C for 24 h under argon yield unique products, possessing interesting molecular structures, respectively, whose characteristic properties and crystal structures are documented, also.     

Synthesis and Crystal Structure of 1-（Trifluoromethyl）-1-（propioloyl）-（E）-3-oxo-（2-thienyl）-（2-naphthylamine）

1INTRODUCTIONTheSchiffbasesderivedfromb-diketonesandaliphaticamineshavebeenshowntoexistastheketo-amines.However,ifsubstituentseitherattheketooraminogrouparearomatic,itmaybeexpectedtheenoliminewillbethefavoredtautomericform[1].Recently,someSchiffbasesderivedfromTTA(4,4,4-trifluoro-1-(2-thienyl)-1,3-butanedione)andPMBPhavebeenstudiedbyWang[2]andYu[3]etal.Inordertostudytherelationshipbetweenthestructuresandperformancesofthesecompounds,thetitlecom-poundwillbereportedherein.2EXPERIMENT…     

Synthesis of (S)-5-(1-aminoethyl)-2-(cyclohexylmethoxy)benzamide

Three short syntheses of the title compound, a peptidomimetic for the Glu-Glu-Ile-NH₂ portion of Ac-pTyr-Glu-Glu-Ile-NH₂, a high affinity peptide for the Src SH2 domain, are described. The most efficient route produces the title compound in a final enantiopurity of 94% ee.     

An Efficient Synthesis of Optically Pure (R)- and (S)-2-(aminomethyl)alanine ((R)- and (S)-ama) and (R)- and (S)-2-(aminomethyl)leucine ((R)- and (S)-aml)

An efficient synthesis of enantiomerically pure (R)- and (S)-2-(aminomethyl)alanine ((R)- and (S)-Ama) 1a and (R)- and (S)-2-(aminomethyl)leucine ((R)- and (S)-Aml) 1b is described (Schemes 1 and 2). Resolution of the racemic amino acids was achieved using L -phenylalanine cyclohexylamide ( 2 ) as chiral auxiliary. The free amino acids 1a, b were converted to the N^α-Boc,N^γ-Z-protected derivatives 11a, b (Scheme 3) ready for incorporation into peptides. Based on the three crystal structures of the diastereoisomeric peptides 8a, 8b , and 9b , the absolute configurations in both series were determined. β-Turn type-I geometries were observed for structures 8b and 9b , whereas 8a crystallized in an extended backbone conformation.     

Total synthesis of (S)-(+)-curcudiol, and (S)-(+)- and (R)-(-)-curcuphenol.

A highly enantioselective synthesis of the versatile chiral synthons possessing one stereogenic center, (S)- and (R)-4-aryl-5-hydroxy-(2E)-pentenoate (3) was achieved based on the enzymatic reaction of (+/-)-3 with commercially available lipases MY-30 or OF-360 from Candida rugosa. Application of (S)-3 and (R)-3 to the total syntheses of(S)-curcuphenol (1), (S)-curcudiol (2), and (R)-curcuphenol (1), respectively, is described.     

Synthesis of (-)-7-epiaustraline and (-)-1-epicastanospermine

Highly efficient and selective syntheses of the title compounds are described. The cornerstone of the synthetic plan is the tandem inter [4 + 2]/inter [3 + 2] cycloaddition process. These syntheses differ from previous applications of this strategy in that they incorporate an alkylation in the hydrogenolysis step to close the second ring of the azabicyclic systems. Notable features of the sequence are (1) the highly regio- and stereoselective [3 + 2] cycloaddition of nitronate 15 with siloxymethyl (Z)-beta-silylvinyl ketone (Z)-22b and (2) the highly selective reduction of the resulting ketone 24a with L-Selectride. A single-crystal X-ray structure analysis of synthetic (-)-7-epiaustraline confirmed that the targeted structure was successfully synthesized. This stimulated a reexamination of the structural assignment of the natural product. (-)-1-Epicastanospermine was synthesized in four steps from the common intermediate 27a. The absolute configuration of (-)-1-epicastanospermine was assured by single-crystal X-ray structure analysis of intermediate (-)-27a. Thus, the sign of the optical rotation had to be revised. The overall efficiency of these syntheses were 9 steps and 23% yield for (-)-7-epiaustraline and 10 steps and 20% yield for (-)-1-epicastanospermine     

Synthesis of (-)-(S)-3-sec-butyl- and (+)-(S)-5-sec-butyl-2(1H)-pyridinone

Optically active (+)-(S)-5-sec-butyl- and (-)-(S)-3-sec-butyl-2(1H)-pyridinone are synthesized and the relationship between optical activity and minimum optical purity of the latter is determined.